A serious issue with esophagogastric balloon tamponade tubes manufactured by BD could cause the devices to break, potentially delaying care for bleeding patients. Clinicians are advised to review and follow updated use instructions.

The Centers for Medicare & Medicaid Services is updating the ACO REACH program—which supports providers caring for rural and low-income populations—to promote patient health as a strategy to reduce costs.

The lawsuits, filed in multiple states, contend there's a causal link between semaglutide and a rare condition called NAION that leads to diminished eyesight. Plaintiffs want the popular weight-loss drugs to add a warning label.

Citing evidence from documents and interviews, the Guardian released an exposé accusing UnitedHealth of directly influencing the day-to-day operations of some 2,000 nursing homes, resulting in patients not receiving necessary emergency care.

The Centers for Medicare & Medicaid Services said it will increase medical coding staff from 40 to 2,000 and begin addressing its backlog of audits on Medicare Advantage plans in an effort to spot signs of fraud and abuse. 

The Ohio-based nonprofit health system did not confirm patient data was exposed and taken by hackers. However, a media report confirmed it has received a ransom notice credited to the Interlock cybercrime cell. 

Erin Strotman, 26, has been charged in a 12-count indictment for incidents of alleged neglect and abuse. Her license to practice nursing has also been suspended, pending trial. 

According to a media report, workers managing records on medical device and tobacco regulations are returning to work after the agency missed court-ordered deadlines for Freedom of Information Act responses. 

Almost 2,000 children underwent musculoskeletal MRI over an eight-year stretch at the Hospital for Special Surgery, and not a single one of them needed sedation to get through the exam.

Indian medtech company Meril Life Sciences has been manufacturing its Myval TAVR valves for years, but FDA approval has remained out of reach. These latest data represent a one-year update of the multicenter LANDMARK clinical trial.